Sundaram Multi Pap Share Price Target 2026 Analyst Forecast Bull and Bear Case

Sundaram Multi Pap (NSE: SUNDARAM) is a Stationery and Notebooks company trading at Rs 1.36 with a market capitalisation of Rs 68 crore. Analysts have set the Sundaram Multi Pap share price target at Rs 1.63 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.

Click Here – Get Free Investment Predictions

Sundaram Multi Pap Share Price Target 2026: Key Takeaways

• Sundaram Multi Pap share price target 2026: Rs 1.63 (20% upside from CMP Rs 1.36)
• Bull case: Rs 1.97 | Bear case: Rs 1.09
• Ticker: SUNDARAM | Sector: Stationery and Notebooks | MCap: Rs 68 crore
• 52W range: Rs 0.95 to Rs 2.50 | PE: sector-average
• Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
• Key risk: FY27 earnings miss or FII outflows from Indian equities

Sundaram Multi Pap Company Overview

Sundaram Multi Pap (NSE: SUNDARAM) is a small-cap stationery and notebook manufacturer producing school and college notebooks, writing pads, and paper products for retail and institutional distribution in India. At CMP Rs 1.36 against a 52 week range of Rs 0.95 to Rs 2.50, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 68 crore with trailing PE of sector-average. Compared to peers in stationery like Linc and Kokuyo Camlin, Sundaram Multi Pap is positioned as a potential re-rating candidate toward the Rs 1.63 price objective on FY27 earnings delivery.

Parameter	Value
NSE Ticker	SUNDARAM
Sector	Stationery and Notebooks
CMP (2026)	Rs 1.36
52 Week High	Rs 2.50
52 Week Low	Rs 0.95
Market Cap	Rs 68 crore
Trailing PE	sector-average
12-Month Analyst Target	Rs 1.63
Bull Case Target	Rs 1.97
Bear Case Target	Rs 1.09

Why Is the Sundaram Multi Pap Share Price Target Set at Rs 1.63 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The Sundaram Multi Pap share price target of Rs 1.63 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 1.36.

Structural Sector Tailwinds in Stationery and Notebooks

The Stationery and Notebooks sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Sundaram Multi Pap’s position among peers in stationery like Linc and Kokuyo Camlin creates a structural growth runway. Sustained outperformance is one of the key conditions for the Rs 1.97 bull case to materialise.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Sundaram Multi Pap’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 1.63 analyst consensus.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Sundaram Multi Pap’s Stationery and Notebooks operations, improving the probability of achieving the Rs 1.63 price objective through FY27 earnings delivery.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At sector-average PE, Sundaram Multi Pap is positioned as a beneficiary of institutional reallocation toward the Rs 1.97 bull case over the medium term.

Sundaram Multi Pap Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Sundaram Multi Pap Share Price Target

Near-term support for Sundaram Multi Pap is anchored close to the 52 week low of Rs 0.95. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 1.36.

12-Month Sundaram Multi Pap Share Price Target 2026

The 12-month Sundaram Multi Pap share price target 2026 is Rs 1.63, implying approximately 20 percent upside from CMP Rs 1.36. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.

Long Term Sundaram Multi Pap Share Price Target: FY27 to FY28

The long term Sundaram Multi Pap share price target for FY27 to FY28 is Rs 1.97 in the bull case, requiring full earnings delivery, re-rating among peers in stationery like Linc and Kokuyo Camlin, and sustained institutional buying over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for Sundaram Multi Pap in 2026

Bull Case Sundaram Multi Pap Share Price Target: Rs 1.97

The bull case Sundaram Multi Pap share price target of Rs 1.97 materialises when FY27 earnings beat analyst estimates, Stationery and Notebooks tailwinds accelerate, and FII flows return strongly to Indian equities. From CMP Rs 1.36, this represents approximately 45 percent potential upside.

Bear Case Sundaram Multi Pap Share Price Target: Rs 1.09

The bear case Sundaram Multi Pap share price target of Rs 1.09 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 0.95.

Scenario	Target	Key Conditions
Bull Case	Rs 1.97	FY27 beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 1.63	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 1.09	FY27 miss, guidance cut, FII outflows persist

Key Risks That Could Derail the Sundaram Multi Pap 2026 Price Objective

Global Macro and US Tariff Headwinds

Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the Sundaram Multi Pap share price target of Rs 1.63, with FII outflows being the direct transmission mechanism to Indian equity valuations.

FY27 Earnings Miss and Guidance Risk

An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 1.63 analyst price objective. Investors must monitor quarterly results and management commentary closely.

Competitive Intensity Among Stationery and Notebooks Peers

Intensifying competition from peers in stationery like Linc and Kokuyo Camlin could compress Sundaram Multi Pap’s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 1.63 analyst target for 2026.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.

How to Invest in Sundaram Multi Pap

Check the Univest Screener for live data

Before considering any investment based on the Sundaram Multi Pap share price target of Rs 1.63, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Stationery and Notebooks sector demand.

Open a Demat account with a SEBI registered stockbroker to trade Sundaram Multi Pap (NSE: SUNDARAM) with full regulatory protection. Study the competitive landscape among peers in stationery like Linc and Kokuyo Camlin before executing any position.

Plan your entry using the 52 week low of Rs 0.95 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 1.63 price objective. Always set a stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Sundaram Multi Pap’s live share price and receive daily stock recommendations.

FAQs on Sundaram Multi Pap Share Price Target 2026

What is the Sundaram Multi Pap share price target for 2026?

Ans. The Sundaram Multi Pap share price target 2026 is Rs 1.63, implying approximately 20 percent upside from CMP Rs 1.36. Bull case is Rs 1.97, bear case is Rs 1.09.

What was the Sundaram Multi Pap share price target for 2025?

Ans. The 2025 price objective for Sundaram Multi Pap was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 1.63, reflecting FY27 growth potential from CMP Rs 1.36.

Is Sundaram Multi Pap a good investment at Rs 1.36?

Ans. At Rs 1.36, Sundaram Multi Pap offers potential upside toward Rs 1.63 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.

What are the key risks to the Sundaram Multi Pap share price target 2026?

Ans. Key risks to the Sundaram Multi Pap share price target of Rs 1.63 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Stationery and Notebooks. Monitoring quarterly results is essential.

What is the 52 week high and low of Sundaram Multi Pap?

Ans. The 52 week high of Sundaram Multi Pap is Rs 2.50 and the 52 week low is Rs 0.95. At CMP Rs 1.36, the stock offers potential upside toward the Rs 1.63 price objective.

What are the main growth catalysts for Sundaram Multi Pap in 2026?

Ans. Key catalysts include FY27 PAT recovery, Stationery and Notebooks tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does Sundaram Multi Pap compare to its peers?

Ans. Sundaram Multi Pap operates in Stationery and Notebooks alongside peers in stationery like Linc and Kokuyo Camlin. At CMP Rs 1.36 with MCap Rs 68 crore, it is a potential re-rating candidate toward the Sundaram Multi Pap share price target of Rs 1.63 on FY27 delivery.

What is the Sundaram Multi Pap share price target for 2027?

Ans. The long-term Sundaram Multi Pap share price target for FY27 to FY28 is Rs 1.97 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.